Pharmaceutical company Galderma has been announced as Headline Sponsor for the Clinical Cosmetic Regenerative Congress (CCR) 2026. Galderma will have a presence across the scientific programme and exhibition floor, providing
The Joint Council for Cosmetic Practitioners (JCCP) has published new guidance for platelet-rich plasma (PRP) procedures within medical aesthetic settings. This guidance was developed by a panel of health protection
The UK Health Security Agency (UKHSA) has issued a warning after a number of individuals presented with botulism symptoms following treatment with botulinum toxin products. The agency said ‘a small
Aesthetic device company Alma has announced that it is the exclusive UK distributor for South Korean biotechnology company ExoCoBio. The partnership aims to expand Alma’s UK portfolio beyond energy-based technologies
Skincare company ALASTIN from pharmaceutical company Galderma has launched C‑Radical Defense Antioxidant Serum. According to the company, the formulation uses an encapsulated form of sodium ascorbate within a proprietary liposomal
New research from the George Washington (GW) University School of Medicine and Health Sciences suggests sensitive skin syndrome (SSS) is biologically distinct from rosacea. Published in the Journal of the
Tweakments Live, the aesthetics and beauty event hosted by The Tweakments Guide, took place on 14 May at The Columbia, London. Guests explored stands from a range of aesthetic and
Aesthetics attended the launch of skincare company Medik8’s new Exo-PDRN Prismatic+ Pro Concentrate. Hosted at the Frameless Immersive Art Experience, the event introduced Medik8’s latest launch, available through aesthetic distributor
Aesthetics has announced the launch of the Aesthetics Results Awards, to be held at the Clinical Cosmetic Regenerative Congress (CCR) 2026. The new initiative is designed to celebrate safe, ethical
The British College of Aesthetic Medicine (BCAM) is urging the public to exercise caution over the increasing promotion of injectable peptide treatments. BCAM states that these treatments are commonly promoted